Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Cardiovascular Diseases
4.2.2 Technological Advancement in Medical Devices
4.2.3 Growing Participation of Government and Private Sector
4.3 Market Restraints
4.3.1 Less Accessibility to New Technology in the Emerging Markets
4.3.2 Irregular Reimbursement Scenario
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Heart Valve Devices
5.1.2 Occluders & Delivery Systems
5.1.3 Annuloplasty Rings
5.1.4 Other Products
5.2 By Procedure
5.2.1 Replacement Procedures
5.2.2 Repair Procedures
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 France
5.3.2.2 Germany
5.3.2.3 United Kingdom
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Biomerics, LLC
6.1.3 Boston Scientific Corporation
6.1.4 Braile Biomedica
6.1.5 Comed B.V.
6.1.6 Edwards Lifesciences Corporation
6.1.7 JenaValve Technology, Inc.
6.1.8 Lepu Medical
6.1.9 LivaNova PLC
6.1.10 Medtronic PLC


7 MARKET OPPORTUNITIES AND FUTURE TRENDS